Friday, December 18, 2020 8:45:12 AM
BMO Capital analyst Do Kim initiated coverage of Exicure with an Outperform rating and $6.00 price target. The company's opportunities in neurological diseases are under-appreciated in spite of the compelling validation for oligonucleotides to correct genetic drivers of hereditary central nervous system disorders, the analyst tells investors in a research note. Kim adds that given the lead drug XCUR-FXN's pre-clinical data and the filing in 2021 to support clinical benefit, he sees a "compelling" risk-reward opportunity for Exicure.
Read more at:
https://thefly.com/n.php?id=3215717
MegaDeath, changed due to circumstances of COVID-19 pandemic.
Recent XCUR News
- Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K • Business Wire • 04/22/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 05:15:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:36:01 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/04/2024 10:37:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:16:37 PM
- Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis • Business Wire • 02/05/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:16:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 11:14:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:21:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 09:19:44 PM
- Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q • Business Wire • 11/28/2023 09:01:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:28:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 09:03:29 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 09:25:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 09:03:38 PM
- Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors • Business Wire • 08/23/2023 01:48:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 01:29:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/18/2023 10:09:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:33:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:18:03 PM
- Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update • Business Wire • 08/11/2023 08:01:00 PM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM